<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04888065</url>
  </required_header>
  <id_info>
    <org_study_id>2018-220</org_study_id>
    <nct_id>NCT04888065</nct_id>
  </id_info>
  <brief_title>Understand the Association Between Peritoneal Dialysis Status and Gene Polymorphisms of VEGF and KDR</brief_title>
  <official_title>Gene Polymorphisms of VEGF and KDR Are Associated With Initial High Transport Status in Peritoneal Dialysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Peritoneal dialysis (PD) is an effective and successful way of renal replacement therapy. The&#xD;
      initial transport status is related to distribution of blood vessels and micro inflammation&#xD;
      state in peritoneum before PD. Vascular endothelial growth factor(VEGF) and its receptor,&#xD;
      kinase insert domain containing receptor(KDR) may play important roles on initial transport&#xD;
      status.&#xD;
&#xD;
      This study include 200 PD patients from Renji Hospital in Shanghai, China. According to the&#xD;
      4h D/P Cr within three months of starting PD therapy, we analyzed the association between the&#xD;
      polymorphisms of VEGF and KDR and initial peritoneal transport property.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 10, 2018</start_date>
  <completion_date type="Actual">December 30, 2020</completion_date>
  <primary_completion_date type="Actual">October 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The relationship between VEGF and KDR Gene polymorphisms and initial transport status in peritoneal dialysis</measure>
    <time_frame>For each patient, the outcome would be cross sectional measured at the time the patient does first/initial Peritoneal Equilibration Test. The data collection time period of the study is within 3 months.</time_frame>
    <description>According to the 4h dialysate over plasma ratio for creatinine （D/P Cr） within three months of starting PD therapy, patients were divided into high transport(H) or high average transport(HA) (H/HA) group and low transport(L) or low average transport(LA) (L/LA) group. Gene polymorphisms of selected VEGF and KDR SNPs were analyzed using extracted blood DNA from these patients. We aimed to investigate the relationship between VEGF and KDR gene polymorphisms and initial peritoneal transport property.</description>
  </primary_outcome>
  <enrollment type="Actual">200</enrollment>
  <condition>Peritoneal Dialysis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Both gender, end stage renal disease on PD treatment&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients are Han Chinese;&#xD;
&#xD;
          2. Patients prepare for dialysis in our center, and start PD within 3 months after&#xD;
             abdominal catheterization;&#xD;
&#xD;
          3. Patients successfully complete the first peritoneal equilibration test(PET);&#xD;
&#xD;
          4. Follow up regularly in our PD center.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients from hemodialysis to peritoneal dialysis;&#xD;
&#xD;
          2. Patients who need peritoneal dialysis due to transplant-renal loss;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>YUE QIAN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>RenJi Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Renji Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>310115</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 27, 2021</study_first_submitted>
  <study_first_submitted_qc>May 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2021</study_first_posted>
  <last_update_submitted>May 10, 2021</last_update_submitted>
  <last_update_submitted_qc>May 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

